CENTRAL LABORATORIES WHITE PAPERS & ARTICLES

• The PMCF Decision Guide

  Proposed EU reforms may remove standalone PMCF reporting, yet the duty to proactively collect clinical data remains. Method selection, notified body defense, and data-capture cost determine what comes next.

• Reimagine Quality: Responding To EOL Deadlines

  Delay, migrate, or reimagine? Learn how rethinking quality operations around AI can triple team productivity and keep you inspection-ready for the next decade.

• Everything Clinical Trial Leaders Need To Know About AI Agents

  A practical guide to what agentic AI actually means for clinical trials, from ontologies and human-in-the-loop governance to continuous validation and the build-versus-buy decision.

• How Clinical Trials Are Moving From Digitized To Agentified

  See how generative and agentic AI can streamline clinical trials, with independent analysis modeling up to $21M in value and 82x ROI for agent-enabled monitoring.

• What Is A Forward Deployed Engineer, And Why Do Clinical Trials Need One?

  See how this model can compress traditional software development from a year or more into months, including a real example of an agent built to automatically detect CTMS milestone errors and anomalies.